1)Lee GA, Williams G, Hirst LW et al:Risk factors in the development of ocular surface epithelial dysplasia. Ophthalmology 101:360-364, 1994
2)有澤武士・成田 信・堀田一樹・他:マイトマイシンC点眼抵抗性の結膜上皮内癌に5-フルオロウラシル点眼が有効であった1例.臨眼 60:571-575,2006
3)鈴村幸史・鈴木久晴・高橋 浩・他:マイトマイシンCの点眼療法が著効した再発角結膜上皮内癌の1症例.眼臨 99:988-991,2005
4)Yeatts RP, Engelbrecht NE, Curry CD et al:5-fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. Ophthalmology 107:2190-2195, 2000
5)Joseph FP, Yaacob R:Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol 21:715-717, 2002
6)伊藤志奈・村戸ドール・島崎 潤・他:角結膜上皮内癌における治療法選択とその効果.あたらしい眼科 23:937-942,2006
7)Yamamoto N, Ohmura T, Suzuki H et al:Successful treatment with 5-fluorouracil of conjunctival intraepithelial neoplasia refractive to mitomycin C. Ophthalmology 109:249-252, 2002
8)Yeatts RP, Ford JG, Stanton CA et al:Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctiva and cornea. Ophthalmology 102:1338-1344, 1995
9)Andress A, Papandroudis MD, Stavros A et al:Mitomycin C therapy for conjunctival-corneal intraepithelial neoplasia. Cornea 21:715-717, 2002
10)Grossniklaus HE, Aaberg TM:Mitomycin C treatment of conjunctival intraepithelial neoplasia. Am J Ophthalmol 124:381-383, 1997
11)Schechter BA, Schrier A, Nagler RS et al:Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Cornea 21:6-11, 2002